nodes	percent_of_prediction	percent_of_DWPC	metapath
Moclobemide—CYP2C19—Sorafenib—liver cancer	0.147	0.251	CbGbCtD
Moclobemide—CYP1A2—Sorafenib—liver cancer	0.135	0.232	CbGbCtD
Moclobemide—CYP2C9—Sorafenib—liver cancer	0.122	0.209	CbGbCtD
Moclobemide—CYP2D6—Sorafenib—liver cancer	0.112	0.191	CbGbCtD
Moclobemide—CYP2D6—Doxorubicin—liver cancer	0.0677	0.116	CbGbCtD
Moclobemide—Bezafibrate—PPARA—liver cancer	0.0088	0.497	CrCbGaD
Moclobemide—Rectal tenesmus—Epirubicin—liver cancer	0.00432	0.0281	CcSEcCtD
Moclobemide—Bezafibrate—PPARG—liver cancer	0.00421	0.238	CrCbGaD
Moclobemide—Rectal tenesmus—Doxorubicin—liver cancer	0.00399	0.026	CcSEcCtD
Moclobemide—Proctalgia—Epirubicin—liver cancer	0.00343	0.0223	CcSEcCtD
Moclobemide—Proctalgia—Doxorubicin—liver cancer	0.00317	0.0207	CcSEcCtD
Moclobemide—Anorectal discomfort—Epirubicin—liver cancer	0.00294	0.0192	CcSEcCtD
Moclobemide—Dry skin—Sorafenib—liver cancer	0.0029	0.0189	CcSEcCtD
Moclobemide—Bezafibrate—CYP1A1—liver cancer	0.00285	0.161	CrCbGaD
Moclobemide—Gastritis—Sorafenib—liver cancer	0.0028	0.0182	CcSEcCtD
Moclobemide—Anorectal discomfort—Doxorubicin—liver cancer	0.00272	0.0177	CcSEcCtD
Moclobemide—Stomatitis—Sorafenib—liver cancer	0.00237	0.0155	CcSEcCtD
Moclobemide—Dermatitis atopic—Epirubicin—liver cancer	0.00217	0.0142	CcSEcCtD
Moclobemide—Gingivitis—Epirubicin—liver cancer	0.00205	0.0133	CcSEcCtD
Moclobemide—Tinnitus—Sorafenib—liver cancer	0.00204	0.0133	CcSEcCtD
Moclobemide—Flushing—Sorafenib—liver cancer	0.00203	0.0132	CcSEcCtD
Moclobemide—Dermatitis atopic—Doxorubicin—liver cancer	0.00201	0.0131	CcSEcCtD
Moclobemide—Gingivitis—Doxorubicin—liver cancer	0.0019	0.0124	CcSEcCtD
Moclobemide—Dysgeusia—Sorafenib—liver cancer	0.00186	0.0121	CcSEcCtD
Moclobemide—Haloperidol—CYP1A1—liver cancer	0.00185	0.104	CrCbGaD
Moclobemide—Syncope—Sorafenib—liver cancer	0.00171	0.0111	CcSEcCtD
Moclobemide—Dysarthria—Epirubicin—liver cancer	0.0017	0.0111	CcSEcCtD
Moclobemide—Loss of consciousness—Sorafenib—liver cancer	0.00167	0.0109	CcSEcCtD
Moclobemide—Hypertension—Sorafenib—liver cancer	0.00164	0.0107	CcSEcCtD
Moclobemide—Myalgia—Sorafenib—liver cancer	0.00162	0.0106	CcSEcCtD
Moclobemide—Dry mouth—Sorafenib—liver cancer	0.00158	0.0103	CcSEcCtD
Moclobemide—Dysarthria—Doxorubicin—liver cancer	0.00157	0.0102	CcSEcCtD
Moclobemide—Shock—Sorafenib—liver cancer	0.00153	0.00995	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00141	0.00922	CcSEcCtD
Moclobemide—Dyspnoea—Sorafenib—liver cancer	0.00138	0.00902	CcSEcCtD
Moclobemide—Dyspepsia—Sorafenib—liver cancer	0.00137	0.0089	CcSEcCtD
Moclobemide—Decreased appetite—Sorafenib—liver cancer	0.00135	0.00879	CcSEcCtD
Moclobemide—Fatigue—Sorafenib—liver cancer	0.00134	0.00872	CcSEcCtD
Moclobemide—Constipation—Sorafenib—liver cancer	0.00133	0.00865	CcSEcCtD
Moclobemide—Gastrointestinal pain—Sorafenib—liver cancer	0.00127	0.00827	CcSEcCtD
Moclobemide—Hot flush—Epirubicin—liver cancer	0.00125	0.00813	CcSEcCtD
Moclobemide—Menopausal symptoms—Epirubicin—liver cancer	0.00124	0.00806	CcSEcCtD
Moclobemide—Urticaria—Sorafenib—liver cancer	0.00123	0.00804	CcSEcCtD
Moclobemide—Abdominal pain—Sorafenib—liver cancer	0.00123	0.008	CcSEcCtD
Moclobemide—Osteoarthritis—Epirubicin—liver cancer	0.00117	0.00761	CcSEcCtD
Moclobemide—Hot flush—Doxorubicin—liver cancer	0.00115	0.00752	CcSEcCtD
Moclobemide—Migraine—Epirubicin—liver cancer	0.00115	0.00749	CcSEcCtD
Moclobemide—Menopausal symptoms—Doxorubicin—liver cancer	0.00114	0.00746	CcSEcCtD
Moclobemide—Asthenia—Sorafenib—liver cancer	0.00111	0.00726	CcSEcCtD
Moclobemide—Pruritus—Sorafenib—liver cancer	0.0011	0.00716	CcSEcCtD
Moclobemide—Osteoarthritis—Doxorubicin—liver cancer	0.00108	0.00704	CcSEcCtD
Moclobemide—Dry skin—Epirubicin—liver cancer	0.00107	0.00697	CcSEcCtD
Moclobemide—Migraine—Doxorubicin—liver cancer	0.00106	0.00693	CcSEcCtD
Moclobemide—Diarrhoea—Sorafenib—liver cancer	0.00106	0.00692	CcSEcCtD
Moclobemide—Gastritis—Epirubicin—liver cancer	0.00103	0.00673	CcSEcCtD
Moclobemide—Dizziness—Sorafenib—liver cancer	0.00103	0.00669	CcSEcCtD
Moclobemide—Abdominal distension—Epirubicin—liver cancer	0.00102	0.00662	CcSEcCtD
Moclobemide—Dry skin—Doxorubicin—liver cancer	0.00099	0.00645	CcSEcCtD
Moclobemide—Vomiting—Sorafenib—liver cancer	0.000987	0.00643	CcSEcCtD
Moclobemide—Angina pectoris—Epirubicin—liver cancer	0.000983	0.0064	CcSEcCtD
Moclobemide—Rash—Sorafenib—liver cancer	0.000979	0.00638	CcSEcCtD
Moclobemide—Dermatitis—Sorafenib—liver cancer	0.000978	0.00637	CcSEcCtD
Moclobemide—Headache—Sorafenib—liver cancer	0.000973	0.00634	CcSEcCtD
Moclobemide—Gastritis—Doxorubicin—liver cancer	0.000956	0.00623	CcSEcCtD
Moclobemide—Dysuria—Epirubicin—liver cancer	0.000943	0.00615	CcSEcCtD
Moclobemide—Abdominal distension—Doxorubicin—liver cancer	0.00094	0.00612	CcSEcCtD
Moclobemide—Nausea—Sorafenib—liver cancer	0.000922	0.00601	CcSEcCtD
Moclobemide—Angina pectoris—Doxorubicin—liver cancer	0.000909	0.00592	CcSEcCtD
Moclobemide—Drowsiness—Epirubicin—liver cancer	0.0009	0.00586	CcSEcCtD
Moclobemide—Stomatitis—Epirubicin—liver cancer	0.000877	0.00571	CcSEcCtD
Moclobemide—Conjunctivitis—Epirubicin—liver cancer	0.000874	0.0057	CcSEcCtD
Moclobemide—Dysuria—Doxorubicin—liver cancer	0.000873	0.00569	CcSEcCtD
Moclobemide—Sweating—Epirubicin—liver cancer	0.000862	0.00562	CcSEcCtD
Moclobemide—Drowsiness—Doxorubicin—liver cancer	0.000832	0.00542	CcSEcCtD
Moclobemide—Bradycardia—Epirubicin—liver cancer	0.000822	0.00536	CcSEcCtD
Moclobemide—Stomatitis—Doxorubicin—liver cancer	0.000811	0.00529	CcSEcCtD
Moclobemide—Conjunctivitis—Doxorubicin—liver cancer	0.000809	0.00527	CcSEcCtD
Moclobemide—Sweating—Doxorubicin—liver cancer	0.000798	0.0052	CcSEcCtD
Moclobemide—Visual impairment—Epirubicin—liver cancer	0.000778	0.00507	CcSEcCtD
Moclobemide—Bradycardia—Doxorubicin—liver cancer	0.000761	0.00496	CcSEcCtD
Moclobemide—Tinnitus—Epirubicin—liver cancer	0.000753	0.00491	CcSEcCtD
Moclobemide—Flushing—Epirubicin—liver cancer	0.00075	0.00488	CcSEcCtD
Moclobemide—Visual impairment—Doxorubicin—liver cancer	0.00072	0.00469	CcSEcCtD
Moclobemide—Tinnitus—Doxorubicin—liver cancer	0.000697	0.00454	CcSEcCtD
Moclobemide—Flushing—Doxorubicin—liver cancer	0.000694	0.00452	CcSEcCtD
Moclobemide—Flatulence—Epirubicin—liver cancer	0.000693	0.00451	CcSEcCtD
Moclobemide—Tension—Epirubicin—liver cancer	0.00069	0.00449	CcSEcCtD
Moclobemide—Dysgeusia—Epirubicin—liver cancer	0.000688	0.00449	CcSEcCtD
Moclobemide—Nervousness—Epirubicin—liver cancer	0.000683	0.00445	CcSEcCtD
Moclobemide—Vision blurred—Epirubicin—liver cancer	0.000663	0.00432	CcSEcCtD
Moclobemide—Ill-defined disorder—Epirubicin—liver cancer	0.000652	0.00425	CcSEcCtD
Moclobemide—Agitation—Epirubicin—liver cancer	0.000646	0.00421	CcSEcCtD
Moclobemide—Flatulence—Doxorubicin—liver cancer	0.000641	0.00418	CcSEcCtD
Moclobemide—Tension—Doxorubicin—liver cancer	0.000638	0.00416	CcSEcCtD
Moclobemide—Dysgeusia—Doxorubicin—liver cancer	0.000637	0.00415	CcSEcCtD
Moclobemide—Malaise—Epirubicin—liver cancer	0.000634	0.00413	CcSEcCtD
Moclobemide—Nervousness—Doxorubicin—liver cancer	0.000632	0.00412	CcSEcCtD
Moclobemide—Syncope—Epirubicin—liver cancer	0.00063	0.00411	CcSEcCtD
Moclobemide—Palpitations—Epirubicin—liver cancer	0.000621	0.00405	CcSEcCtD
Moclobemide—Loss of consciousness—Epirubicin—liver cancer	0.000618	0.00403	CcSEcCtD
Moclobemide—Vision blurred—Doxorubicin—liver cancer	0.000613	0.00399	CcSEcCtD
Moclobemide—Hypertension—Epirubicin—liver cancer	0.000607	0.00395	CcSEcCtD
Moclobemide—Ill-defined disorder—Doxorubicin—liver cancer	0.000604	0.00393	CcSEcCtD
Moclobemide—Chest pain—Epirubicin—liver cancer	0.000599	0.0039	CcSEcCtD
Moclobemide—Myalgia—Epirubicin—liver cancer	0.000599	0.0039	CcSEcCtD
Moclobemide—Agitation—Doxorubicin—liver cancer	0.000598	0.00389	CcSEcCtD
Moclobemide—Anxiety—Epirubicin—liver cancer	0.000596	0.00389	CcSEcCtD
Moclobemide—Discomfort—Epirubicin—liver cancer	0.000591	0.00385	CcSEcCtD
Moclobemide—Malaise—Doxorubicin—liver cancer	0.000587	0.00382	CcSEcCtD
Moclobemide—Dry mouth—Epirubicin—liver cancer	0.000585	0.00381	CcSEcCtD
Moclobemide—Syncope—Doxorubicin—liver cancer	0.000583	0.0038	CcSEcCtD
Moclobemide—Confusional state—Epirubicin—liver cancer	0.000579	0.00377	CcSEcCtD
Moclobemide—Palpitations—Doxorubicin—liver cancer	0.000575	0.00375	CcSEcCtD
Moclobemide—Loss of consciousness—Doxorubicin—liver cancer	0.000572	0.00372	CcSEcCtD
Moclobemide—Shock—Epirubicin—liver cancer	0.000564	0.00368	CcSEcCtD
Moclobemide—Hypertension—Doxorubicin—liver cancer	0.000562	0.00366	CcSEcCtD
Moclobemide—Tachycardia—Epirubicin—liver cancer	0.00056	0.00365	CcSEcCtD
Moclobemide—Hyperhidrosis—Epirubicin—liver cancer	0.000555	0.00361	CcSEcCtD
Moclobemide—Myalgia—Doxorubicin—liver cancer	0.000554	0.00361	CcSEcCtD
Moclobemide—Chest pain—Doxorubicin—liver cancer	0.000554	0.00361	CcSEcCtD
Moclobemide—Anxiety—Doxorubicin—liver cancer	0.000552	0.0036	CcSEcCtD
Moclobemide—Discomfort—Doxorubicin—liver cancer	0.000547	0.00356	CcSEcCtD
Moclobemide—Dry mouth—Doxorubicin—liver cancer	0.000542	0.00353	CcSEcCtD
Moclobemide—Hypotension—Epirubicin—liver cancer	0.000536	0.00349	CcSEcCtD
Moclobemide—Confusional state—Doxorubicin—liver cancer	0.000535	0.00349	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000523	0.00341	CcSEcCtD
Moclobemide—Shock—Doxorubicin—liver cancer	0.000522	0.0034	CcSEcCtD
Moclobemide—Insomnia—Epirubicin—liver cancer	0.000519	0.00338	CcSEcCtD
Moclobemide—Tachycardia—Doxorubicin—liver cancer	0.000518	0.00338	CcSEcCtD
Moclobemide—Paraesthesia—Epirubicin—liver cancer	0.000515	0.00336	CcSEcCtD
Moclobemide—Hyperhidrosis—Doxorubicin—liver cancer	0.000513	0.00334	CcSEcCtD
Moclobemide—Dyspnoea—Epirubicin—liver cancer	0.000512	0.00333	CcSEcCtD
Moclobemide—Somnolence—Epirubicin—liver cancer	0.00051	0.00332	CcSEcCtD
Moclobemide—Dyspepsia—Epirubicin—liver cancer	0.000505	0.00329	CcSEcCtD
Moclobemide—Decreased appetite—Epirubicin—liver cancer	0.000499	0.00325	CcSEcCtD
Moclobemide—Hypotension—Doxorubicin—liver cancer	0.000496	0.00323	CcSEcCtD
Moclobemide—Fatigue—Epirubicin—liver cancer	0.000495	0.00322	CcSEcCtD
Moclobemide—Constipation—Epirubicin—liver cancer	0.000491	0.0032	CcSEcCtD
Moclobemide—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000484	0.00315	CcSEcCtD
Moclobemide—Insomnia—Doxorubicin—liver cancer	0.00048	0.00313	CcSEcCtD
Moclobemide—Paraesthesia—Doxorubicin—liver cancer	0.000477	0.00311	CcSEcCtD
Moclobemide—Dyspnoea—Doxorubicin—liver cancer	0.000473	0.00308	CcSEcCtD
Moclobemide—Feeling abnormal—Epirubicin—liver cancer	0.000473	0.00308	CcSEcCtD
Moclobemide—Somnolence—Doxorubicin—liver cancer	0.000472	0.00307	CcSEcCtD
Moclobemide—Gastrointestinal pain—Epirubicin—liver cancer	0.000469	0.00306	CcSEcCtD
Moclobemide—Dyspepsia—Doxorubicin—liver cancer	0.000467	0.00304	CcSEcCtD
Moclobemide—Decreased appetite—Doxorubicin—liver cancer	0.000462	0.00301	CcSEcCtD
Moclobemide—Fatigue—Doxorubicin—liver cancer	0.000458	0.00298	CcSEcCtD
Moclobemide—Urticaria—Epirubicin—liver cancer	0.000456	0.00297	CcSEcCtD
Moclobemide—Constipation—Doxorubicin—liver cancer	0.000454	0.00296	CcSEcCtD
Moclobemide—Abdominal pain—Epirubicin—liver cancer	0.000454	0.00296	CcSEcCtD
Moclobemide—Feeling abnormal—Doxorubicin—liver cancer	0.000437	0.00285	CcSEcCtD
Moclobemide—Gastrointestinal pain—Doxorubicin—liver cancer	0.000434	0.00283	CcSEcCtD
Moclobemide—Urticaria—Doxorubicin—liver cancer	0.000422	0.00275	CcSEcCtD
Moclobemide—Abdominal pain—Doxorubicin—liver cancer	0.00042	0.00273	CcSEcCtD
Moclobemide—Asthenia—Epirubicin—liver cancer	0.000412	0.00268	CcSEcCtD
Moclobemide—Pruritus—Epirubicin—liver cancer	0.000406	0.00264	CcSEcCtD
Moclobemide—Diarrhoea—Epirubicin—liver cancer	0.000393	0.00256	CcSEcCtD
Moclobemide—Asthenia—Doxorubicin—liver cancer	0.000381	0.00248	CcSEcCtD
Moclobemide—Dizziness—Epirubicin—liver cancer	0.000379	0.00247	CcSEcCtD
Moclobemide—Pruritus—Doxorubicin—liver cancer	0.000376	0.00245	CcSEcCtD
Moclobemide—Vomiting—Epirubicin—liver cancer	0.000365	0.00238	CcSEcCtD
Moclobemide—Diarrhoea—Doxorubicin—liver cancer	0.000363	0.00237	CcSEcCtD
Moclobemide—Rash—Epirubicin—liver cancer	0.000362	0.00236	CcSEcCtD
Moclobemide—Dermatitis—Epirubicin—liver cancer	0.000361	0.00235	CcSEcCtD
Moclobemide—Headache—Epirubicin—liver cancer	0.000359	0.00234	CcSEcCtD
Moclobemide—Dizziness—Doxorubicin—liver cancer	0.000351	0.00229	CcSEcCtD
Moclobemide—Nausea—Epirubicin—liver cancer	0.000341	0.00222	CcSEcCtD
Moclobemide—Vomiting—Doxorubicin—liver cancer	0.000338	0.0022	CcSEcCtD
Moclobemide—Rash—Doxorubicin—liver cancer	0.000335	0.00218	CcSEcCtD
Moclobemide—Dermatitis—Doxorubicin—liver cancer	0.000334	0.00218	CcSEcCtD
Moclobemide—Headache—Doxorubicin—liver cancer	0.000333	0.00217	CcSEcCtD
Moclobemide—Nausea—Doxorubicin—liver cancer	0.000315	0.00205	CcSEcCtD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000204	0.000834	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—GSTM1—liver cancer	0.000202	0.000825	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—liver cancer	0.000201	0.00082	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—liver cancer	0.0002	0.000818	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—GSTM1—liver cancer	0.0002	0.000818	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CPT1B—liver cancer	0.000199	0.000814	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GLUL—liver cancer	0.000199	0.000814	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—GSTM1—liver cancer	0.000199	0.000814	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	0.000198	0.000807	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000193	0.000789	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NR1H4—liver cancer	0.000192	0.000785	CbGpPWpGaD
Moclobemide—CYP2D6—Biological oxidations—CYP1A1—liver cancer	0.000192	0.000782	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—TNF—liver cancer	0.000191	0.00078	CbGpPWpGaD
Moclobemide—CYP2C9—Biological oxidations—CYP1A1—liver cancer	0.00019	0.000775	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTA3—liver cancer	0.000189	0.000772	CbGpPWpGaD
Moclobemide—CYP2D6—Metapathway biotransformation—CYP1A1—liver cancer	0.000189	0.000771	CbGpPWpGaD
Moclobemide—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	0.000187	0.000765	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—liver cancer	0.000187	0.000764	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—liver cancer	0.000187	0.000764	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000186	0.000761	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—GSTP1—liver cancer	0.000186	0.00076	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000186	0.000758	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	0.000184	0.00075	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—RAF1—liver cancer	0.000184	0.00075	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PSMA4—liver cancer	0.000182	0.000745	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PSMD10—liver cancer	0.000182	0.000745	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GOT2—liver cancer	0.000178	0.000725	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTA4—liver cancer	0.000173	0.000706	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—GSTM1—liver cancer	0.000171	0.000699	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	0.000169	0.000689	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTA2—liver cancer	0.000168	0.000688	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP2E1—liver cancer	0.000167	0.000681	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000165	0.000674	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTA1—liver cancer	0.000163	0.000664	CbGpPWpGaD
Moclobemide—CYP1A2—Biological oxidations—CYP1A1—liver cancer	0.000162	0.000662	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—NAT2—liver cancer	0.000161	0.000656	CbGpPWpGaD
Moclobemide—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	0.00016	0.000653	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000159	0.00065	CbGpPWpGaD
Moclobemide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000158	0.000644	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000156	0.000638	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYCS—liver cancer	0.000156	0.000638	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—UGDH—liver cancer	0.000156	0.000636	CbGpPWpGaD
Moclobemide—MAOA—SIDS Susceptibility Pathways—IL6—liver cancer	0.000154	0.000629	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALDOB—liver cancer	0.000154	0.000629	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GGT1—liver cancer	0.000153	0.000626	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GOT1—liver cancer	0.000153	0.000626	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CRABP1—liver cancer	0.000147	0.0006	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—EPT1—liver cancer	0.000146	0.000598	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—UGDH—liver cancer	0.000143	0.000585	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000142	0.000582	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—UGDH—liver cancer	0.000142	0.00058	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—TAT—liver cancer	0.000139	0.000567	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GSTP1—liver cancer	0.000138	0.000562	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000137	0.000557	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—HMOX1—liver cancer	0.000136	0.000554	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—EPT1—liver cancer	0.000135	0.00055	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—EPT1—liver cancer	0.000134	0.000545	CbGpPWpGaD
Moclobemide—MAOA—Transmission across Chemical Synapses—HRAS—liver cancer	0.000132	0.000539	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—HPGDS—liver cancer	0.000128	0.000525	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—TAT—liver cancer	0.000128	0.000521	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—TAT—liver cancer	0.000127	0.000517	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—GSTM1—liver cancer	0.000126	0.000516	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000125	0.000508	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000122	0.000497	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—UGDH—liver cancer	0.000121	0.000495	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—CYP1A1—liver cancer	0.00012	0.00049	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PSMA4—liver cancer	0.000115	0.000467	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PSMD10—liver cancer	0.000115	0.000467	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—EPT1—liver cancer	0.000114	0.000466	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—MTHFR—liver cancer	0.000112	0.000456	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GOT2—liver cancer	0.000111	0.000455	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PPARA—liver cancer	0.00011	0.000448	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—TAT—liver cancer	0.000108	0.000442	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000106	0.000434	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP2E1—liver cancer	0.000105	0.000428	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000102	0.000417	CbGpPWpGaD
Moclobemide—MAOA—Neuronal System—HRAS—liver cancer	0.000101	0.000413	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYCS—liver cancer	9.8e-05	0.0004	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GGT1—liver cancer	9.62e-05	0.000393	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GOT1—liver cancer	9.62e-05	0.000393	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CPT1B—liver cancer	9.44e-05	0.000385	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GLUL—liver cancer	9.44e-05	0.000385	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CG—liver cancer	9.39e-05	0.000383	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	9.32e-05	0.00038	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NR1H4—liver cancer	9.1e-05	0.000372	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PPARG—liver cancer	9.06e-05	0.00037	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTA3—liver cancer	8.95e-05	0.000365	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CPT1B—liver cancer	8.68e-05	0.000354	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GLUL—liver cancer	8.68e-05	0.000354	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTP1—liver cancer	8.64e-05	0.000353	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CPT1B—liver cancer	8.6e-05	0.000351	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GLUL—liver cancer	8.6e-05	0.000351	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—HMOX1—liver cancer	8.52e-05	0.000348	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NR1H4—liver cancer	8.37e-05	0.000342	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NR1H4—liver cancer	8.3e-05	0.000339	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CD—liver cancer	8.26e-05	0.000337	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTA3—liver cancer	8.23e-05	0.000336	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTA4—liver cancer	8.18e-05	0.000334	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTA3—liver cancer	8.16e-05	0.000333	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—ALB—liver cancer	8.15e-05	0.000333	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	8e-05	0.000326	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTA2—liver cancer	7.97e-05	0.000326	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	7.96e-05	0.000325	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—GSTM1—liver cancer	7.94e-05	0.000324	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTA1—liver cancer	7.69e-05	0.000314	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—NAT2—liver cancer	7.61e-05	0.000311	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTA4—liver cancer	7.53e-05	0.000307	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—CYP1A1—liver cancer	7.52e-05	0.000307	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTA4—liver cancer	7.46e-05	0.000305	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GLUL—liver cancer	7.35e-05	0.0003	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CPT1B—liver cancer	7.35e-05	0.0003	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTA2—liver cancer	7.33e-05	0.000299	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	7.31e-05	0.000299	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALDOB—liver cancer	7.29e-05	0.000298	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	7.29e-05	0.000298	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTA2—liver cancer	7.27e-05	0.000297	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CB—liver cancer	7.2e-05	0.000294	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NR1H4—liver cancer	7.09e-05	0.000289	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTA1—liver cancer	7.08e-05	0.000289	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—MTHFR—liver cancer	7.01e-05	0.000286	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTA1—liver cancer	7.01e-05	0.000286	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—NAT2—liver cancer	7e-05	0.000286	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA3—liver cancer	6.97e-05	0.000285	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CRABP1—liver cancer	6.96e-05	0.000284	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—NAT2—liver cancer	6.94e-05	0.000283	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PPARA—liver cancer	6.88e-05	0.000281	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALDOB—liver cancer	6.71e-05	0.000274	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.67e-05	0.000272	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALDOB—liver cancer	6.65e-05	0.000271	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CRABP1—liver cancer	6.4e-05	0.000261	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA4—liver cancer	6.38e-05	0.00026	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CRABP1—liver cancer	6.34e-05	0.000259	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	6.26e-05	0.000256	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	6.23e-05	0.000254	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA2—liver cancer	6.21e-05	0.000254	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HPGDS—liver cancer	6.08e-05	0.000248	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	6.05e-05	0.000247	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTA1—liver cancer	5.99e-05	0.000245	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—NAT2—liver cancer	5.93e-05	0.000242	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CG—liver cancer	5.89e-05	0.000241	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.71e-05	0.000233	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	5.7e-05	0.000233	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PPARG—liver cancer	5.69e-05	0.000232	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALDOB—liver cancer	5.68e-05	0.000232	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HPGDS—liver cancer	5.59e-05	0.000228	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HPGDS—liver cancer	5.54e-05	0.000226	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.51e-05	0.000225	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.51e-05	0.000225	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.44e-05	0.000222	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CRABP1—liver cancer	5.42e-05	0.000221	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PSMD10—liver cancer	5.42e-05	0.000221	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PSMA4—liver cancer	5.42e-05	0.000221	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GOT2—liver cancer	5.27e-05	0.000215	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CD—liver cancer	5.18e-05	0.000212	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—ALB—liver cancer	5.11e-05	0.000209	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.02e-05	0.000205	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PSMA4—liver cancer	4.99e-05	0.000204	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PSMD10—liver cancer	4.99e-05	0.000204	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP2E1—liver cancer	4.96e-05	0.000202	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.96e-05	0.000202	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PSMD10—liver cancer	4.94e-05	0.000202	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PSMA4—liver cancer	4.94e-05	0.000202	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.88e-05	0.000199	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GOT2—liver cancer	4.85e-05	0.000198	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GOT2—liver cancer	4.81e-05	0.000196	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.8e-05	0.000196	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HPGDS—liver cancer	4.74e-05	0.000193	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	4.71e-05	0.000192	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYCS—liver cancer	4.64e-05	0.000189	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP2E1—liver cancer	4.56e-05	0.000186	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GOT1—liver cancer	4.55e-05	0.000186	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GGT1—liver cancer	4.55e-05	0.000186	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP2E1—liver cancer	4.52e-05	0.000185	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CB—liver cancer	4.52e-05	0.000184	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—PIK3CA—liver cancer	4.39e-05	0.000179	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.38e-05	0.000179	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.29e-05	0.000175	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYCS—liver cancer	4.27e-05	0.000174	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.24e-05	0.000173	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYCS—liver cancer	4.23e-05	0.000173	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PSMA4—liver cancer	4.22e-05	0.000172	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PSMD10—liver cancer	4.22e-05	0.000172	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GOT1—liver cancer	4.19e-05	0.000171	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GGT1—liver cancer	4.19e-05	0.000171	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GOT1—liver cancer	4.15e-05	0.000169	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GGT1—liver cancer	4.15e-05	0.000169	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GOT2—liver cancer	4.11e-05	0.000168	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTP1—liver cancer	4.09e-05	0.000167	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—HMOX1—liver cancer	4.03e-05	0.000165	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP2E1—liver cancer	3.86e-05	0.000158	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTP1—liver cancer	3.76e-05	0.000154	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—GSTM1—liver cancer	3.76e-05	0.000153	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.74e-05	0.000153	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTP1—liver cancer	3.73e-05	0.000152	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—HMOX1—liver cancer	3.71e-05	0.000151	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—HMOX1—liver cancer	3.68e-05	0.00015	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYCS—liver cancer	3.61e-05	0.000148	CbGpPWpGaD
Moclobemide—MAOB—Metabolism—AKT1—liver cancer	3.58e-05	0.000146	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—CYP1A1—liver cancer	3.56e-05	0.000145	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GGT1—liver cancer	3.55e-05	0.000145	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GOT1—liver cancer	3.55e-05	0.000145	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—GSTM1—liver cancer	3.46e-05	0.000141	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—GSTM1—liver cancer	3.43e-05	0.00014	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—MTHFR—liver cancer	3.32e-05	0.000136	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—CYP1A1—liver cancer	3.28e-05	0.000134	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARA—liver cancer	3.26e-05	0.000133	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—CYP1A1—liver cancer	3.25e-05	0.000133	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTP1—liver cancer	3.19e-05	0.00013	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—HMOX1—liver cancer	3.14e-05	0.000128	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—MTHFR—liver cancer	3.05e-05	0.000125	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—MTHFR—liver cancer	3.03e-05	0.000124	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARA—liver cancer	3e-05	0.000122	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARA—liver cancer	2.97e-05	0.000121	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—GSTM1—liver cancer	2.93e-05	0.00012	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.93e-05	0.000119	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CG—liver cancer	2.79e-05	0.000114	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—CYP1A1—liver cancer	2.77e-05	0.000113	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—PIK3CA—liver cancer	2.75e-05	0.000112	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PPARG—liver cancer	2.69e-05	0.00011	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.67e-05	0.000109	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—MTHFR—liver cancer	2.59e-05	0.000106	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CG—liver cancer	2.57e-05	0.000105	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CG—liver cancer	2.54e-05	0.000104	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARA—liver cancer	2.54e-05	0.000104	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PPARG—liver cancer	2.48e-05	0.000101	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PPARG—liver cancer	2.45e-05	0.0001	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CD—liver cancer	2.45e-05	0.0001	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—ALB—liver cancer	2.42e-05	9.88e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.28e-05	9.31e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CD—liver cancer	2.26e-05	9.21e-05	CbGpPWpGaD
Moclobemide—MAOA—Metabolism—AKT1—liver cancer	2.25e-05	9.18e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CD—liver cancer	2.24e-05	9.13e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—ALB—liver cancer	2.23e-05	9.09e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—ALB—liver cancer	2.21e-05	9.01e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CG—liver cancer	2.17e-05	8.87e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CB—liver cancer	2.14e-05	8.73e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PPARG—liver cancer	2.1e-05	8.56e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CB—liver cancer	1.97e-05	8.03e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CB—liver cancer	1.95e-05	7.96e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CD—liver cancer	1.91e-05	7.8e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—ALB—liver cancer	1.89e-05	7.7e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CB—liver cancer	1.67e-05	6.8e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—PIK3CA—liver cancer	1.3e-05	5.32e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—PIK3CA—liver cancer	1.2e-05	4.89e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—PIK3CA—liver cancer	1.19e-05	4.85e-05	CbGpPWpGaD
Moclobemide—CYP2C19—Metabolism—AKT1—liver cancer	1.06e-05	4.35e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—PIK3CA—liver cancer	1.02e-05	4.15e-05	CbGpPWpGaD
Moclobemide—CYP2D6—Metabolism—AKT1—liver cancer	9.79e-06	4e-05	CbGpPWpGaD
Moclobemide—CYP2C9—Metabolism—AKT1—liver cancer	9.71e-06	3.96e-05	CbGpPWpGaD
Moclobemide—CYP1A2—Metabolism—AKT1—liver cancer	8.29e-06	3.39e-05	CbGpPWpGaD
